Somatic hypermutation shapes the viral escape profile of SARS-CoV-2 neutralising antibodiesResearch in context
Summary: Background: Since the onset of the COVID-19 pandemic, SARS-CoV-2 neutralising monoclonal antibodies (mAbs) are being developed for clinical use. With the appearance of new virus variants, most mAbs lost their virus-neutralising activity, highlighting the complexity of mAb development under...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2025-06-01
|
| coleção: | EBioMedicine |
| Assuntos: | |
| Acesso em linha: | http://www.sciencedirect.com/science/article/pii/S2352396425002142 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
